Results 231 to 240 of about 45,247 (265)

Interleukin-6 Protects against Fas-mediated Death by Establishing a Critical Level of Anti-apoptotic Hepatic Proteins FLIP, Bcl-2, and Bcl-xL [PDF]

, 2001
Kellen Kovalovich, Wěi Li, Robert A. DeAngelis, Linda E. Greenbaum, Gennaro Ciliberto, Rebecca Taub   +5 more
openalex   +1 more source

Beyond Conventional Approaches: The Revolutionary Role of Nanoparticles in Breast Cancer

MedComm – Biomaterials and Applications, Volume 4, Issue 2, June 2025.
This review explores integrated approach of nanotechnology to breast cancer diagnosis and treatment. We highlight imaging techniques for tumor detection and biomarker analysis in biological samples for early diagnosis. Advanced therapies, including targeted drug delivery and antibody‐drug conjugates, enable precise medication transport to cancer cells,
Mohan Liu, Yusi Wang, Yan Li, Yibing Zhang, Bailing Zhou, Lei Yang, Xi Yan, Li Yang   +7 more
wiley   +1 more source

Helicobacter-induced expression of Bcl-xL in B lymphocytes in the mouse model — An important step in the development of gastric malt lymphoma

, 2000
Andrea Morgner, Philip Sutton, Jani O’Rourke, Angelina Enno, Michael F. Dixon, Adrian V. Lee   +5 more
openalex   +1 more source

Epidermal Growth Factor Receptor-dependent Control of Keratinocyte Survival and Bcl-xL Expression through a MEK-dependent Pathway [PDF]

, 2001
Monika Jost, Teresa M. Huggett, Csaba Kari, Lawrence Boise, Ulrich Rodeck   +4 more
openalex   +1 more source

CtBP2 Regulates Wnt Signal Through EGR1 to Influence the Proliferation and Apoptosis of DLBCL Cells

Molecular Carcinogenesis, Volume 64, Issue 6, Page 959-969, June 2025.
ABSTRACT Diffuse large B‐cell lymphoma (DLBCL) is the most prevalent form of lymphoma. The overexpression of CtBP2 in tissues may contribute to tumor occurrence and progression. The expression of EGR1 in DLBCL is elevated, suggesting its potential role as an oncogene that promotes the proliferation of DLBCL cells.
Jianfang Dong, Lihua Li, Xuefei Zhang, Xijing Yin, Zucong Chen   +4 more
wiley   +1 more source

NITRIC OXIDE-MEDIATED INDUCTION OF BCL-2 AND BCL-XL IN PORCINE ENDOTHELIAL CELLS AFTER EXPOSURE TO LOW CONCENTRATIONS OF XENOREACTIVE NATURAL ANTIBODY.

, 2000
Anthony Dorling, Alexandros Delikouras, Monica Prasad Hayes, Prupti Malde, Robert I. Lechler   +4 more
openalex   +1 more source

Abstracts

Molecular Oncology, Volume 19, Issue S1, Page 1-895, June 2025.
Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Mitochondrial Transplantation: A Novel Therapeutic Approach for Treating Diseases

MedComm, Volume 6, Issue 6, June 2025.
This article describes the roles of mitochondria in health and disease and reviews the effects of mitochondrial transplantation in disease, including restoring ATP production, attenuating oxidative stress, modulating inflammatory responses, reducing apoptosis, promoting cell repair, and exhibiting antitumor properties.
Xinglu Miao, Pei Jiang, Zhaoping Wang, Weihua Kong, Lei Feng   +4 more
wiley   +1 more source

Unlocking T‐Cell Plasticity in the Tumor Microenvironment: Implications for Cancer Progression and Therapeutic Strategies

MedComm – Oncology, Volume 4, Issue 2, June 2025.
The tumor microenvironment (TME) shapes T‐cell plasticity, influencing cancer progression and therapeutic outcomes. Here, we summarize the phenotypic transitions and spatial distribution of T cells within the TME, highlighting their dual roles in therapeutic efficacy and resistance.
Xiao‐Hong Ding, Xue‐Pei Li, Fenfang Chen, Han Wang, Yi‐Zhou Jiang   +4 more
wiley   +1 more source

BAD/BCL-xL heterodimerization leads to bypass of G0/G1 arrest

, 2001
Anuja Chattopadhyay, Chi-Wu Chiang, Elizabeth Yang   +2 more
openalex   +1 more source